Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
Incyte Corporation
Hackensack Meridian Health
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Fate Therapeutics
Bristol-Myers Squibb
Presage Biosciences
Medical College of Wisconsin
National Cancer Institute (NCI)
MultiVir, Inc.
EpicentRx, Inc.